AxoGen, Inc. (AXGN)
NASDAQ: AXGN · IEX Real-Time Price · USD
7.52
-0.19 (-2.46%)
At close: Jul 2, 2024, 4:00 PM
7.57
+0.05 (0.66%)
After-hours: Jul 2, 2024, 4:19 PM EDT
AxoGen Revenue
AxoGen had revenue of $163.73M in the twelve months ending March 31, 2024, with 13.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $41.38M with 12.86% year-over-year growth. In the year 2023, AxoGen had annual revenue of $159.01M with 14.74% growth.
Revenue (ttm)
$163.73M
Revenue Growth
+13.51%
P/S Ratio
2.01
Revenue / Employee
$384,333
Employees
426
Market Cap
328.66M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 159.01M | 20.43M | 14.74% |
Dec 31, 2022 | 138.58M | 11.23M | 8.81% |
Dec 31, 2021 | 127.36M | 15.06M | 13.41% |
Dec 31, 2020 | 112.30M | 5.59M | 5.24% |
Dec 31, 2019 | 106.71M | 22.78M | 27.13% |
Dec 31, 2018 | 83.94M | 23.51M | 38.91% |
Dec 31, 2017 | 60.43M | 19.32M | 46.99% |
Dec 31, 2016 | 41.11M | 13.78M | 50.41% |
Dec 31, 2015 | 27.33M | 10.51M | 62.52% |
Dec 31, 2014 | 16.82M | 5.87M | 53.62% |
Dec 31, 2013 | 10.95M | 3.26M | 42.33% |
Dec 31, 2012 | 7.69M | 2.84M | 58.61% |
Dec 31, 2011 | 4.85M | 1.85M | 61.41% |
Dec 31, 2010 | 3.00M | -21.91M | -87.94% |
Dec 31, 2009 | 24.91M | 24.84M | 34,160.81% |
Dec 31, 2008 | 72.71K | -27.72K | -27.60% |
Dec 31, 2007 | 100.43K | -26.23K | -20.71% |
Dec 31, 2006 | 126.66K | -316.69K | -71.43% |
Dec 31, 2005 | 443.35K | -621.65K | -58.37% |
Dec 31, 2004 | 1.07M | - | - |
Dec 31, 2003 | 0 | - | - |
Dec 31, 2002 | 6.85M | -8.11M | -54.19% |
Dec 31, 2001 | 14.96M | 1.54M | 11.49% |
Jun 30, 2000 | 13.42M | 1.14M | 9.26% |
Jun 30, 1999 | 12.28M | -643.29K | -4.98% |
Jun 30, 1998 | 12.92M | 666.04K | 5.43% |
Jun 30, 1997 | 12.26M | -844.43K | -6.45% |
Jun 30, 1996 | 13.10M | -1.04M | -7.34% |
Jun 30, 1995 | 14.14M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pacific Biosciences of California | 200.43M |
Vanda Pharmaceuticals | 177.60M |
Scilex Holding Company | 47.05M |
C4 Therapeutics | 20.04M |
Verrica Pharmaceuticals | 8.91M |
Absci | 5.35M |
AXGN News
- 1 day ago - Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 8 days ago - Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™ - GlobeNewsWire
- 5 weeks ago - Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia - GlobeNewsWire
- 2 months ago - Axogen, Inc Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ - GlobeNewsWire
- 2 months ago - Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 - GlobeNewsWire
- 4 months ago - Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results - GlobeNewsWire
- 5 months ago - Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 - GlobeNewsWire